Posted on 28/10/02
Ailing drug stocks seen making a slow recovery
Drug stocks have been under the weather this year -- even compared with the sickly performance of the broader stock market.Investors are worried about drug pipelines, competition from generics and U.S. legislators who want to limit drug costs.
The full text of this article has 954 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
